These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

688 related items for PubMed ID: 32957532

  • 21. [Replication Machinery of Kaposi's Sarcoma-associated Herpesvirus and Drug Discovery Research].
    Watanabe T, Fujimuro M.
    Yakugaku Zasshi; 2019; 139(1):69-73. PubMed ID: 30606932
    [Abstract] [Full Text] [Related]

  • 22. Activation of Kaposi's sarcoma-associated herpesvirus (KSHV) by inhibitors of class III histone deacetylases: identification of sirtuin 1 as a regulator of the KSHV life cycle.
    Li Q, He M, Zhou F, Ye F, Gao SJ.
    J Virol; 2014 Jun; 88(11):6355-67. PubMed ID: 24672028
    [Abstract] [Full Text] [Related]

  • 23. Kaposi's sarcoma-associated herpesvirus terminal repeat regulates inducible lytic gene promoters.
    Izumiya Y, Algalil A, Espera JM, Miura H, Izumiya C, Inagaki T, Kumar A.
    J Virol; 2024 Feb 20; 98(2):e0138623. PubMed ID: 38240593
    [Abstract] [Full Text] [Related]

  • 24. KSHV Genome Replication and Maintenance in Latency.
    Ueda K.
    Adv Exp Med Biol; 2018 Feb 20; 1045():299-320. PubMed ID: 29896673
    [Abstract] [Full Text] [Related]

  • 25. Nuclear Innate Immune DNA Sensor IFI16 Is Degraded during Lytic Reactivation of Kaposi's Sarcoma-Associated Herpesvirus (KSHV): Role of IFI16 in Maintenance of KSHV Latency.
    Roy A, Dutta D, Iqbal J, Pisano G, Gjyshi O, Ansari MA, Kumar B, Chandran B.
    J Virol; 2016 Oct 01; 90(19):8822-41. PubMed ID: 27466416
    [Abstract] [Full Text] [Related]

  • 26. Acetylation changes at lysine 5 of histone H4 associated with lytic gene promoters during reactivation of Kaposi's sarcoma-associated herpesvirus.
    Hwang LR, Cha S, Jong JE, Jang JH, Seo T.
    Acta Virol; 2014 Oct 01; 58(3):282-6. PubMed ID: 25283865
    [Abstract] [Full Text] [Related]

  • 27. Nuclear Localization and Cleavage of STAT6 Is Induced by Kaposi's Sarcoma-Associated Herpesvirus for Viral Latency.
    Wang C, Zhu C, Wei F, Gao S, Zhang L, Li Y, Feng Y, Tong Y, Xu J, Wang B, Yuan Z, Robertson ES, Cai Q.
    PLoS Pathog; 2017 Jan 01; 13(1):e1006124. PubMed ID: 28099521
    [Abstract] [Full Text] [Related]

  • 28. Reduction of Kaposi's Sarcoma-Associated Herpesvirus Latency Using CRISPR-Cas9 To Edit the Latency-Associated Nuclear Antigen Gene.
    Tso FY, West JT, Wood C.
    J Virol; 2019 Apr 01; 93(7):. PubMed ID: 30651362
    [Abstract] [Full Text] [Related]

  • 29. Identification of Novel Kaposi's Sarcoma-Associated Herpesvirus Orf50 Transcripts: Discovery of New RTA Isoforms with Variable Transactivation Potential.
    Wakeman BS, Izumiya Y, Speck SH.
    J Virol; 2017 Jan 01; 91(1):. PubMed ID: 27795414
    [Abstract] [Full Text] [Related]

  • 30. Intracellular-activated Notch1 can reactivate Kaposi's sarcoma-associated herpesvirus from latency.
    Lan K, Murakami M, Choudhuri T, Kuppers DA, Robertson ES.
    Virology; 2006 Aug 01; 351(2):393-403. PubMed ID: 16701788
    [Abstract] [Full Text] [Related]

  • 31. Nucleophosmin phosphorylation by v-cyclin-CDK6 controls KSHV latency.
    Sarek G, Järviluoma A, Moore HM, Tojkander S, Vartia S, Biberfeld P, Laiho M, Ojala PM.
    PLoS Pathog; 2010 Mar 19; 6(3):e1000818. PubMed ID: 20333249
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. RUNX3 inhibits KSHV lytic replication by binding to the viral genome and repressing transcription.
    Ren P, Niu D, Chang S, Yu L, Ren J, Ma Y, Lan K.
    J Virol; 2024 Feb 20; 98(2):e0156723. PubMed ID: 38197631
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. The Latency-Associated Nuclear Antigen of Kaposi's Sarcoma-Associated Herpesvirus Inhibits Expression of SUMO/Sentrin-Specific Peptidase 6 To Facilitate Establishment of Latency.
    Lin X, Sun R, Zhang F, Gao Y, Bin L, Lan K.
    J Virol; 2017 Sep 01; 91(17):. PubMed ID: 28615201
    [Abstract] [Full Text] [Related]

  • 39. Lytic but not latent infection by Kaposi's sarcoma-associated herpesvirus requires host CSL protein, the mediator of Notch signaling.
    Liang Y, Ganem D.
    Proc Natl Acad Sci U S A; 2003 Jul 08; 100(14):8490-5. PubMed ID: 12832621
    [Abstract] [Full Text] [Related]

  • 40. Targeting Kaposi's Sarcoma-Associated Herpesvirus ORF21 Tyrosine Kinase and Viral Lytic Reactivation by Tyrosine Kinase Inhibitors Approved for Clinical Use.
    Beauclair G, Naimo E, Dubich T, Rückert J, Koch S, Dhingra A, Wirth D, Schulz TF.
    J Virol; 2020 Feb 14; 94(5):. PubMed ID: 31826996
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 35.